Prof. Enis Özyar is a Professor of Radiation Oncology with a medical degree from Hacettepe University Faculty of Medicine (2003). He brings extensive clinical and leadership experience, including work with Acıbadem Health Group since 2008. His clinical focus and research are centered on therapeutic radiology and oncology, and he is actively involved in cancer prevention and treatment initiatives. Professor Özyar is a member of numerous national and international professional organizations, including the Radiation Oncology Society, Turkish Cancer Research and Fighting Organization, Turkish Oncology Society, Hacettepe Oncology Institute Association, Oncology Institute Foundation, Balkan Union of Oncology, the European Society for Therapeutic Radiology and Oncology (ESTRO), and the American Society for Therapeutic Radiology and Oncology (ASTRO). Committed to advancing patient care and oncology research, he combines academic expertise with practical experience to improve treatment outcomes and promote multidisciplinary collaboration in cancer care.
Education
- 2003 Hacettepe University Faculty of Medicine / Professor
- 1997 Hacettepe University Faculty of Medicine / Associate Professor
- 1993 Hacettepe University Faculty of Medicine Radiation Oncology
- 1979 – 1985 Ankara University Faculty of Medicine
Experience
- 2008 Acibadem Health Group
- 1987 – 2008 Department of Radiation Oncology, Hacettepe University Faculty of Medicine
- 1985 – 1987 Ministry of Labor and Social Security, Compulsory Service , Ankara
- 1985 – 1987 Istanbul University Istanbul Faculty of Medicine Department of Anesthesiology and Reanimation
Memberships
- Radiation Oncology Society
- Turkish Cancer Research and Fighting Organization
- Turkish Oncology Society
- Hacettepe Oncology Institute Association
- Oncology Institute Foundation
- Balkan Union of Oncology
- European Society of Therapeutic Radiology and Oncology
- American Society of Therapeutic Radiology and Oncology
Publications
- Treatment results and prognostic factors in primary thyroid lymphoma patients: a rare cancer network study.
Onal C, Li YX, Miller RC, Poortmans P, Constantinou N, Weber DC, Atasoy BM, Igdem S, Ozsahin M, Ozyar E. Ann Oncol. 2011 Jan;22(1):156-64 - Prognostic significance of tumor volume in nasopharyngeal carcinoma.
Sarisahin M, Cila A, Ozyar E, Yildiz F, Turen S. Auris Nasus Larynx. 2011 Apr;38(2):250-4 - T4N0M0 nasopharyngeal carcinoma patients: do they have a distinct tumor biology?
Atasoy BM, Ozyar E, Akman F, Esassolak M, Abacioğlu U. Kulak Burun Bogaz Ihtis Derg. 2010 Mar-Apr;20(2):89-96 - Isolated hypoglossal nerve paralysis: a case report.
Beriat GK, Ezerarslan H, Kocatürk S, Özyar E. Kulak Burun Bogaz Ihtis Derg. 2010 Jul-Aug;20(4):205-9 - Symmetrical primary cutaneous marginal zone lymphoma associated with rheumatoid arthritis.
J Cutan Pathol. 2010 May;37(5):600-4 Yildirim FE, Karaduman A, Hürmüz P, Ozyar E, Barishta I, Saglam A. - Pediatric and young adult nasopharyngeal carcinoma patients treated with preradiation Cisplatin and docetaxel chemotherapy.
Int J Radiat Oncol Biol Phys. 2009 Mar 15;73(4):1116-20 Varan A, Ozyar E, Corapcioglu F, Kosal Y, Aydin B, Yazici N, Akyuz C, Buyukpamukcu M. - The treatment of childhood Hodgkin lymphoma: improved survival in a developing country.
Büyükpamukçu M, Varan A, Akyüz C, Atahan L, Ozyar E, Kale G, Köksal Y, Kutluk T. Acta Oncol. 2009;48(1):44-51 - Pediatric and young adult nasopharyngeal carcinoma patients treated with preradiation Cisplatin and docetaxel chemotherap
Int J Radiat Oncol Biol Phys. 2009 Mar 15;73(4):1116-20 Varan A, Ozyar E, Corapcioglu F, Kosal Y, Aydin B, Yazici N, Akyuz C, Buyukpamukcu M. - Bimodal age distribution in Hodgkin’s disease and nasopharyngeal carcinoma
Barista I, Varan A, Ozyar E. Med Hypotheses. 2007;68(6):1421. Epub 2006 Dec 29
